Search Results - Maarten Postma

Refine Results
  1. 1

    The implementation of community-based programs in Vietnam is promising in promoting health by Zinzi E. Pardoel, Sijmen A. Reijneveld, Robert Lensink, Maarten Postma, Maarten Postma, Maarten Postma, Maarten Postma, Tran B. Thuy, Nga C. Viet, Lien N. T. Phuong, Jaap A. R. Koot, Jeanet J. A. Landsman

    Published in Frontiers in Public Health (2023-06-01)
    Get full text
    Article


  2. 2

    Absenteeism and Productivity Loss Due to Influenza or Influenza-like Illness in Adults in Europe and North America by David Fisman, Maarten Postma, Myron J. Levin, Joaquin Mould-Quevedo

    Published in Diseases (2024-12-01)
    Get full text
    Article


  3. 3

    Maintaining the value of influenza vaccination – the shift from quadrivalent to trivalent vaccines: an expert review by David Fisman, Alberto Pérez-Rubio, Maarten Postma, Darvin S. Smith, Joaquin Mould-Quevedo

    Published in Expert Review of Vaccines (2025-12-01)
    Get full text
    Article


  4. 4

    Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands by Bart Slob, Tanja Fens, Maaike Weersma, Maarten Postma, Cornelis Boersma, Lisa de Jong

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  5. 5

    Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands. by Bart Slob, Tanja Fens, Maaike Weersma, Maarten Postma, Cornelis Boersma, Lisa de Jong

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  6. 6

    Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus. by Gijs Hubben, Martin Bootsma, Michiel Luteijn, Diarmuid Glynn, David Bishai, Marc Bonten, Maarten Postma

    Published in PLoS ONE (2011-03-01)
    Get full text
    Article


  7. 7

    Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis by Leyla Yumrukaya, Arnold Hagens, Ahmet Çağkan İnkaya, Gökhan Metan, Maarten Postma, Selen Yeğenoğlu, Murat Akova

    Published in Antibiotics (2025-06-01)
    Get full text
    Article


  8. 8

    An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands by Jos Luttjeboer, Joost Simons, Tjalke Westra, Jan Wilschut, Cornelis Boersma, Maarten Postma, Jurjen van der Schans

    Published in Infectious Diseases and Therapy (2023-08-01)
    Get full text
    Article


  9. 9

    Economic Assessment of High-Dose Versus Adjuvanted Influenza Vaccine: An Evaluation of Hospitalization Costs Based on a Cohort Study by Robertus van Aalst, Stefan Gravenstein, Vincent Mor, Salaheddin M. Mahmud, Jan Wilschut, Maarten Postma, Ayman Chit

    Published in Vaccines (2021-09-01)
    Get full text
    Article


  10. 10

    Differences in knowledge, attitude, and practice regarding hypertension by access to a community-based screening program (POSBINDU): A cross-sectional study from four districts in... by Yusuf Ari Mashuri, Vitri Widyaningsih, Alimah Premanawasti, Jaap Koot, Zinzi Pardoel, Jeanet Landsman-Dijkstra, Maarten Postma, Ari Probandari

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  11. 11

    Differences in knowledge, attitude, and practice regarding hypertension by access to a community-based screening program (POSBINDU): A cross-sectional study from four districts in... by Yusuf Ari Mashuri, Vitri Widyaningsih, Alimah Premanawasti, Jaap Koot, Zinzi Pardoel, Jeanet Landsman-Dijkstra, Maarten Postma, Ari Probandari

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  12. 12

    Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data by Mark H. Rozenbaum, Elizabeth Begier, Samantha K. Kurosky, Jo Whelan, Danai Bem, Koen B. Pouwels, Maarten Postma, Louis Bont

    Published in Infectious Diseases and Therapy (2023-05-01)
    Get full text
    Article


  13. 13

    Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion by Maarten Postma, David Fisman, Norberto Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña, Joaquin Mould-Quevedo

    Published in Vaccines (2023-06-01)
    Get full text
    Article


  14. 14

    COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey by Arnold Hagens, Ahmet Çağkan İnkaya, Kasirga Yildirak, Mesut Sancar, Jurjen van der Schans, Aylin Acar Sancar, Serhat Ünal, Maarten Postma, Selen Yeğenoğlu

    Published in Vaccines (2021-04-01)
    Get full text
    Article


  15. 15

    Economic and humanistic burden of HPV-related disease in Indonesia: A qualitative analysis by Marisa Felsher, Didik Setiawan, Stefan Varga, Richard Perry, Danielle Riley, Rebecca Newman, Abigail Beveridge, Charlotte Oswald, Smita Kothari, Isaya Sukarom, Maarten Postma

    Published in Global Public Health (2023-01-01)
    Get full text
    Article


  16. 16

    The economic rationale for cell-based influenza vaccines in children and adults: A review of cost-effectiveness analyses by David Fisman, Norberto Giglio, Myron J. Levin, Van Hung Nguyen, Stephen I. Pelton, Maarten Postma, Jesús Ruiz-Aragón, Analia Urueña, Joaquin F. Mould-Quevedo

    Published in Human Vaccines & Immunotherapeutics (2024-12-01)
    Get full text
    Article


  17. 17

    Impact of digital interdisciplinary consultation on secondary care referrals by general practitioners: a protocol for a stepped-wedge cluster randomised controlled trial by Maarten Postma, Danielle Jansen, Henk van der Worp, Marco H Blanker, Henk Schers, Sanne Sanavro, Joke Stoffelen, Paul Koning, Michiel de Boer, Guus Janus

    Published in BMJ Open (2022-12-01)
    Get full text
    Article


  18. 18

    Efficiency of Diagnostic Testing for <i>Helicobacter pylori</i> Infections—A Systematic Review by Paula Rojas García, Simon van der Pol, Antoinette D. I. van Asselt, Maarten Postma, Roberto Rodríguez-Ibeas, Carmelo A. Juárez-Castelló, Marino González, Fernando Antoñanzas

    Published in Antibiotics (2021-01-01)
    Get full text
    Article


  19. 19

    Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines by Eleanor Bell, Simon Brassel, Edward Oliver, Hannah Schirrmacher, Sofie Arnetorp, Katja Berg, Duncan Darroch-Thompson, Paula Pohja-Hutchison, Bruce Mungall, Stuart Carroll, Maarten Postma, Lotte Steuten

    Published in Vaccines (2022-08-01)
    Get full text
    Article


  20. 20

    Cost analysis and cost-effectiveness of open versus laparoscopic versus robot-assisted versus transanal total mesorectal excision in patients with rectal cancer: a protocol for a s... by Maarten Postma, Roel Hompes, Klaas Havenga, Esther C J Consten, Ritchie T J Geitenbeek, Thijs A Burghgraef, Mark Broekman, Bram P A Schop, Tom G F Lieverse

    Published in BMJ Open (2022-08-01)
    Get full text
    Article


Search Tools: